SCHEMBL3838372

SCHEMBL3838372

COc1ccc(C=O)c(Oc2ccc(Cl)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.67
▸ CYP1A2 P05177 4/20 0.57
▸ LMNA P02545 3/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ TRIM24 O15164 1/20 0.51
▸ TYR P14679 1/20 0.51
▸ TRIM33 Q9UPN9 1/20 0.51
▸ MAPT P10636 6/20 0.51
▸ HPGD P15428 1/20 0.51
▸ ERN1 O75460 3/20 0.47
▸ CYP1A1 P04798 3/20 0.47
▸ CYP1B1 Q16678 3/20 0.47
▸ TDP1 Q9NUW8 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ ABCG2 Q9UNQ0 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065366 0.85 ALDH1A1 (0.59) ALDH1A1CYP1A2LMNACYP2C9CYP2C19
SCHEMBL19563634 0.85 ALDH1A1 (0.64) ALDH1A1CYP1A2LMNACYP2C9CYP2C19
SCHEMBL19563670 0.82 ALDH1A1 (0.55) ALDH1A1CYP1A2LMNACYP2C9CYP2C19
SCHEMBL96291 0.81 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP2C9CYP2C19TRIM24
SCHEMBL2419953 0.81 ALDH1A1 (0.61) ALDH1A1CYP1A2LMNACYP2C9CYP2C19
SCHEMBL5989078 0.81 HTR2A (0.52) ALDH1A1CYP1A2LMNACYP2C9CYP2C19
Hydrochloric Acid SCHEMBL9456784 0.79 ALDH1A1 (0.96) ALDH1A1CYP1A2CYP2C9CYP2C19TRIM24
SCHEMBL9400065 0.79 PDE7A (0.54) ALDH1A1LMNATRIM24TYRTRIM33
SCHEMBL20346747 0.78 ALDH1A1 (0.63) ALDH1A1CYP1A2LMNACYP2C9CYP2C19
SCHEMBL24068855 0.78 ALDH1A1 (0.79) ALDH1A1CYP1A2LMNACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884061-B2 Compositions and methods of use of electron transport system inhibitors COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2014-11-11 — — US disclosed
US-20090030084-A1 Compositions and Methods of Use of Electron Transport System Inhibitors NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030084-A1 Compositions and Methods of Use of Electron Transport System Inhibitors ABCB11, SLC8B1, SLC47A1 ALDH1A1 1221/4885CYP1A2 392/4885LMNA 3436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback